search
Back to results

Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema (HCPAPvsHFNC)

Primary Purpose

Cardiogenic Pulmonary Edema

Status
Completed
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
hCPAP versus HFNC
Sponsored by
Hospital Raja Permaisuri Bainun
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiogenic Pulmonary Edema focused on measuring non invasive ventilation, pulmonary edema, high flow nasal cannula, helmet CPAP, respiratory failure, hyperaemia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

All patients aged more than 18 years old presented with acute cardiogenic pulmonary oedema.

Exclusion Criteria:

  1. Age less than 18 years old
  2. Low GCS (less than 8), altered mental status
  3. Hemodynamic instability, impending cardiopulmonary arrest
  4. Use of vasopressors, inotropes
  5. Exacerbation of asthma or chronic respiratory failure
  6. Urgent need for endotracheal intubation
  7. Absence of airway protective gag reflex
  8. Elevated intracranial pressure
  9. Tracheostomy
  10. Pregnant
  11. Upper airway obstruction
  12. Injuries or surgery to head and neck less than 6 months upon presentation
  13. Claustrophobia
  14. Blind or poor vision
  15. Medico-legal related cases

Sites / Locations

  • Emergency Department, Hospital Raja Permaisuri Bainun

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Helmet Continuous Positive Airway Pressure(hCPAP)

High Flow Nasal Cannula(HFNC)

Arm Description

Helmet CPAP produce a better physiological outcomes after 1-hour intervention

HFNC produce a better physiological outcomes after 1-hour intervention

Outcomes

Primary Outcome Measures

Respiratory Rate
Respiratory rate reduction post intervention

Secondary Outcome Measures

Heart Rate
Heart rate reduction post intervention
Partial Pressure Of Arterial Oxygen Level
Partial arterial oxygen level post intervention
Ratio Of Partial Pressure Arterial Oxygen And Fraction Of Oxygen
Partial arterial oxygen/fraction of oxygen ratio improvement post intervention
Dyspnoea Scale
Dyspnoea scale improvement post intervention.Dyspnea scale measured using an unmarked 10cm VAS card that had mark with "I can breathe normally", at one end correspond to patients' normal baseline breathing which score "0" and on the other end "I can't breathe at all", which score "10" represent the worst difficulty perceived by patients.
Heart Rate,Acidosis (pH), Consciousness (GCS), Oxygenation (PF ratio) And Respiratory Rate(HACOR) Score
Heart rate,Acidosis (pH), Consciousness (GCS), Oxygenation (PF ratio) and Respiratory rate(HACOR) Score improvement post intervention.HACOR is an acronym for heart rate, acidosis (pH), consciousness (GCS), oxygenation (PF ratio) and respiratory rate in which each parameter is an independent predictor for NIV failure. HACOR score is out of 25 with differential weighting of each parameter.
Rate Of Intubation
Intubation rate post intervention
28-Days Mortality In Acute Cardiogenic Pulmonary Edema
Mortality due to Acute Cardiogenic Pulmonary Edema

Full Information

First Posted
June 27, 2019
Last Updated
January 18, 2021
Sponsor
Hospital Raja Permaisuri Bainun
search

1. Study Identification

Unique Protocol Identification Number
NCT04005092
Brief Title
Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema
Acronym
HCPAPvsHFNC
Official Title
Helmet Continuous Positive Airway Pressure Versus High Flow Nasal Cannula Oxygen in Acute Cardiogenic Pulmonary Oedema: A Randomized Control Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
January 1, 2018 (Actual)
Primary Completion Date
August 31, 2018 (Actual)
Study Completion Date
September 30, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Raja Permaisuri Bainun

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study objectively held to compare the physiological outcomes in the non-invasive (NIV) treatment of Acute Cardiogenic Pulmonary Oedema (ACPE) patients in the Emergency Department (ED) delivered by Helmet CPAP (hCPAP) and HFNC.Patients will be randomized to receive either hCPAP or HFNC.
Detailed Description
Non-invasive ventilation(NIV) has different types of interfaces that had been used in acute hypoxaemic and hypercapnic respiratory failure. The appropriate interface is necessary to provide comfort and lead to the success of NIV. Helmet continuous positive airway pressure (hCPAP) is an NIV interface that allows the provision of high airway pressures with a minimal leak. HFNC which delivers heated humidified high flow oxygen provides a good alternative to the conventional NIV in terms of comfort

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiogenic Pulmonary Edema
Keywords
non invasive ventilation, pulmonary edema, high flow nasal cannula, helmet CPAP, respiratory failure, hyperaemia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
188 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Helmet Continuous Positive Airway Pressure(hCPAP)
Arm Type
Active Comparator
Arm Description
Helmet CPAP produce a better physiological outcomes after 1-hour intervention
Arm Title
High Flow Nasal Cannula(HFNC)
Arm Type
Active Comparator
Arm Description
HFNC produce a better physiological outcomes after 1-hour intervention
Intervention Type
Device
Intervention Name(s)
hCPAP versus HFNC
Intervention Description
The patient presented with Acute Cardiogenic Pulmonary Edema will be randomized into either helmet CPAP or HFNC.
Primary Outcome Measure Information:
Title
Respiratory Rate
Description
Respiratory rate reduction post intervention
Time Frame
1 hour
Secondary Outcome Measure Information:
Title
Heart Rate
Description
Heart rate reduction post intervention
Time Frame
1 hour
Title
Partial Pressure Of Arterial Oxygen Level
Description
Partial arterial oxygen level post intervention
Time Frame
1 hour
Title
Ratio Of Partial Pressure Arterial Oxygen And Fraction Of Oxygen
Description
Partial arterial oxygen/fraction of oxygen ratio improvement post intervention
Time Frame
1 hour
Title
Dyspnoea Scale
Description
Dyspnoea scale improvement post intervention.Dyspnea scale measured using an unmarked 10cm VAS card that had mark with "I can breathe normally", at one end correspond to patients' normal baseline breathing which score "0" and on the other end "I can't breathe at all", which score "10" represent the worst difficulty perceived by patients.
Time Frame
1 hour
Title
Heart Rate,Acidosis (pH), Consciousness (GCS), Oxygenation (PF ratio) And Respiratory Rate(HACOR) Score
Description
Heart rate,Acidosis (pH), Consciousness (GCS), Oxygenation (PF ratio) and Respiratory rate(HACOR) Score improvement post intervention.HACOR is an acronym for heart rate, acidosis (pH), consciousness (GCS), oxygenation (PF ratio) and respiratory rate in which each parameter is an independent predictor for NIV failure. HACOR score is out of 25 with differential weighting of each parameter.
Time Frame
1 hour
Title
Rate Of Intubation
Description
Intubation rate post intervention
Time Frame
1 hour
Title
28-Days Mortality In Acute Cardiogenic Pulmonary Edema
Description
Mortality due to Acute Cardiogenic Pulmonary Edema
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All patients aged more than 18 years old presented with acute cardiogenic pulmonary oedema. Exclusion Criteria: Age less than 18 years old Low GCS (less than 8), altered mental status Hemodynamic instability, impending cardiopulmonary arrest Use of vasopressors, inotropes Exacerbation of asthma or chronic respiratory failure Urgent need for endotracheal intubation Absence of airway protective gag reflex Elevated intracranial pressure Tracheostomy Pregnant Upper airway obstruction Injuries or surgery to head and neck less than 6 months upon presentation Claustrophobia Blind or poor vision Medico-legal related cases
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
ADI OSMAN
Organizational Affiliation
EMERGENCY DEPARTMENT, HOSPITAL RAJA PERMAISURI BAINUN, IPOH, PERAK, MALAYSIA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Emergency Department, Hospital Raja Permaisuri Bainun
City
Ipoh
State/Province
Perak
ZIP/Postal Code
30450
Country
Malaysia

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34632507
Citation
Osman A, Via G, Sallehuddin RM, Ahmad AH, Fei SK, Azil A, Mojoli F, Fong CP, Tavazzi G. Helmet continuous positive airway pressure vs. high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: a randomized controlled trial. Eur Heart J Acute Cardiovasc Care. 2021 Dec 18;10(10):1103-1111. doi: 10.1093/ehjacc/zuab078.
Results Reference
derived

Learn more about this trial

Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema

We'll reach out to this number within 24 hrs